Skip to main content

Table 2 shows baseline characteristics of enrolled patients

From: Histidine–tryptophan–ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis

Study ID Study arms Age (years) Male sex Weight (Kg) Medical history NYHA class
Smoking Diabetes mellitus Hypertension Hyperlipidemia 1 2 3 4 Average
Ali et al. [16] HTK 44.19 ± 11.63 118 (73.8%) 56 (35%) 72 (45%) 80 (50%) 8 (5%) 56 (35%) 80 (50%) 16 (10%)
  MDC 43.11 ± 10.7 120 (75%) 40 (25%) 56 (35%) 72 (45%) 8 (5%) 80 (50%) 56 (35%) 16 (10%)
Cvetković et al. [17] HTK 64.5 ± 6.5 40 (74.1%) 21 (38.9%) 24 (44.4%) 40 (74.1%) 24 (44.4%) 1.57 ± 0.6
  MDC 65.3 ± 6.3 44 (88%) 21 (42%) 20(40%) 44 (88%) 24 (48%) 1.6 ± 0.62
Vivacqua et al. [18] HTK 63 ± 13 29 (52.7%) 83 ± 17 11 (20%) 32 (58.2%) 39 (70.9%)
  MDC 70 ± 11 35 (63.6%) 90 ± 22 12 (21.8%) 45 (81.8%) 44 (81.5%)
Gaudino et al. [19] HTK 64 ± 9 25 (80.7%) 15 (48.4%) 9 (29%)
  MDC 61 ± 5 21 (72.4%) 18 (62.1%) 7 (24.1%)
Mercan et al. [25] HTK 60.1 ± 7.8 19 (76%) 12 (48%)* 17 (68%) 9 (36%)
  MDC 62.7 ± 9.4 21 (84%) 13 (52%)* 12 (48%) 12 (48%)
Kammerer et al. [20] HTK 65 ± 14 31 (56.4%) 74 ± 13 5 (9.1%)
  MDC 66 ± 9 36 (69.2%) 77 ± 19 4 (7.7%)
Braathen et al. [10] HTK 59 ± 2 34 (89.5%) 86 ± 3
  MDC 59 ± 2 25 (65.8%) 80 ± 2
Demmy et al. [21] HTK 62 67 (98.5%)
  MDC   61 (89.7%)
Arslan et al. [22] HTK 60.23 ± 5.6 16 (76.2%) 78.4 ± 11.9
  MDC 60.38 ± 7.3 19 (90.5%) 75.6 ± 13.2
Careaga et al. [23] HTK 53 ± 19.75 21 (70%)
  MDC   
Beyersdorf et al. [24] HTK 58 ± 7 9 (75%) 7 (58.3%) 0 (0%) 3 (25%) 7 (58.3%) 0 (0%) 0 (0%) 12 (100%) 0 (0%)
  MDC 59 ± 8 9 (75%) 8 (66.7%) 2 (16.7%) 4 (33.3%) 10 (83.3%) 0 (0%) 4 (33.3%) 7 (58.3%) 1 (8.3%)
Gallandat huet et al. [6] HTK 60.7 ± 8.8 107 (81.1%)
  MDC 60.7 ± 7.6 94 (80.3%)
  1. Data were presented as mean ± standard deviation or number (%)
  2. NYHA: New York Heart Association Functional Classification
  3. *Type-2 diabetes mellitus